DNAJB3 attenuates ER stress through direct interaction with AKT

PLoS One. 2023 Aug 18;18(8):e0290340. doi: 10.1371/journal.pone.0290340. eCollection 2023.

Abstract

Metabolic stress involved in several dysregulation disorders such as type 2 diabetes mellitus (T2DM) results in down regulation of several heat shock proteins (HSPs) including DNAJB3. This down regulation of HSPs is associated with insulin resistance (IR) and interventions which induce the heat shock response (HSR) help to increase the insulin sensitivity. Metabolic stress leads to changes in signaling pathways through increased activation of both c-jun N-terminal kinase-1 (JNK1) and the inhibitor of κB inflammatory kinase (IKKβ) which in turn leads to inactivation of insulin receptor substrates 1 and 2 (IRS-1 and IRS-2). DNAJB3 interacts with both JNK1 and IKKβ kinases to mitigate metabolic stress. In addition DNAJB3 also activates the PI3K-PKB/AKT pathway through increased phosphorylation of AKT1 and its substrate AS160, a Rab GTPase-activating protein, which results in mobilization of GLUT4 transporter protein and improved glucose uptake. We show through pull down that AK T1 is an interacting partner of DNAJB3, further confirmed by isothermal titration calorimetry (ITC) which quantified the avidity of AKT1 for DNAJB3. The binding interface was identified by combining protein modelling with docking of the AKT1-DNAJB3 complex. DNAJB3 is localized in the cytoplasm and ER, where it interacts directly with AKT1 and mobilizes AS160 for glucose transport. Inhibition of AKT1 resulted in loss of GLUT4 translocation activity mediated by DNAJB3 and also abolished the protective effect of DNAJB3 on tunicamycin-induced ER stress. Taken together, our findings provide evidence for a direct protein-protein interaction between DNAJB3 and AKT1 upon which DNAJB3 alleviates ER stress and promotes GLUT4 translocation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Diabetes Mellitus, Type 2*
  • HSP40 Heat-Shock Proteins
  • Heat-Shock Proteins
  • Humans
  • I-kappa B Kinase
  • Insulin Resistance*
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt

Substances

  • I-kappa B Kinase
  • Proto-Oncogene Proteins c-akt
  • Protein Serine-Threonine Kinases
  • Heat-Shock Proteins
  • DNAJB3 protein, human
  • HSP40 Heat-Shock Proteins

Grants and funding

Qatar National Research Fund: NPRP11S-0102-180172; QBRI: IGP-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.